Financial News
Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
May 22, 2025 at 15:56 PM EDT
Dr. Draskovic joined Solomon Eye in 2017 and has consistently demonstrated exceptional expertise in the diagnosis and management of complex ocular conditions. Her collaborative approach, dedication to patient outcomes, and passion for education have made her an invaluable asset to both patients and colleagues alike.
In this new role, Dr. Draskovic will lead the clinical strategy for the Ocular Disease division, supporting best-in-class protocols, mentoring clinical staff, and driving continued advancement in treatment options for conditions such as dry eye, glaucoma, macular degeneration, and diabetic eye disease.
"Dr. Draskovic's promotion reflects both her outstanding clinical leadership and our continued focus on delivering top-tier, patient-centered care," said Dr. Jonathan Solomon, Medical Director at Solomon Eye. "She brings the perfect balance of experience, innovation, and compassion to this role."
Dr. Draskovic holds her Doctor of Optometry from The New England College of Optometry with residency training at the Baltimore VA Medical Center focused on ocular disease. She is an active member of the American Academy of Optometry and frequently lectures on advancements in disease management and interdisciplinary care.
"I'm honored to take on this position and work alongside a team so deeply committed to improving the lives of our patients," said Dr. Draskovic. "Together, we'll continue to raise the standard of care in our community."
For more information about Solomon Eye Physicians and Surgeons and its full range of services, visit www.solomoneye.com.
Photos: (Click photo to enlarge)
Source: Solomon Eye
Read Full Story - Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease | More news from this source
Press release distribution by PRLog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
